Insmed

INSM62

$66.57arrow_drop_down6.94%-$4.95

INSM62

$66.57

arrow_drop_down6.94%-$4.95

Performance History

Key Stats
Open	$71.26
Prev. Close	$71.26
EPS	-5.16
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	66.01	71.79
52 Week Range	21.92	81.39

Ratios







EPS	-5.16

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Insmed (INSM)

Insmed Inc (INSM) is a biopharmaceutical company that focuses on developing and commercializing therapies for patients with serious and rare diseases. The company is committed to improving the lives of patients suffering from conditions with limited treatment options. With a strong pipeline of innovative drugs, Insmed Inc is dedicated to bringing new therapies to market that address unmet medical needs.

Insmed Inc's stock price history shows a steady upward trend over the past few years. Investors have been optimistic about the company's prospects and its ability to deliver on its pipeline. The stock has performed well, outperforming the broader market and generating significant returns for shareholders. This positive performance has been driven by strong clinical trial results, FDA approvals, and successful commercial launches of its products.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. William H. Lewis J.D., M.B.A.
Headquarters: Bridgewater
Employees: 736
Exchange: NASDAQ

Keep an eye on Insmed

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Insmed 's (INSM) price per share?

The current price per share for Insmed (INSM) is $66.58. The stock has seen a price change of -$4.95 recently, indicating a -6.95% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Insmed (INSM)?

For Insmed (INSM), the 52-week high is $81.39, which is 22.26% from the current price. The 52-week low is $21.92, the current price is 203.72% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Insmed (INSM) a growth stock?

Insmed (INSM) has shown an average price growth of -6.65% over the past three years. It has received a score of 88 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Insmed as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Insmed (INSM) stock price performance year to date (YTD)?

As of the latest data, Insmed (INSM) has a year-to-date price change of 122.36%. Over the past month, the stock has experienced a price change of -10.36%. Over the last three months, the change has been -14.2%. Over the past six months, the figure is 168.77%. Looking at a longer horizon, the five-year price change stands at 231.05%.

help

Is Insmed (INSM) a profitable company?

Insmed (INSM) has a net income of -$749.57M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 78.52% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -212.73% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $305.21M, with a revenue growth rate of 24.39%, providing insight into the company's sales performance and growth. The gross profit is $239.64M. Operating income is noted at -$709.63M. Furthermore, the EBITDA is -$695.06M.

help

What is the market capitalization of Insmed (INSM)?

Insmed (INSM) has a market capitalization of $11.86B. The average daily trading volume is 67.22, indicating the stock's liquidity and investor engagement.